\-\ Texto\\:\\ \ \(0\)\
\-\ swelling\\ and\\ edema\\ in\\ the\\ left\\ periorbital\\ region\\ with\\ a\\ depressed\\ globe\\ \\(enophthalmos\\)\\.\ \(0\)\
\-\ because\\ of\\ the\\ damage\\ from\\ rupture\\,\\ the\\ patient\\ had\\ an\\ enucleation\\ of\\ the\\ left\\ globe\\.\ \(0\)\
\-\ \\Â\\»\\ abnormal\\ morphology\\ and\\ contour\\ of\\ the\\ left\\ globe\\ with\\ associated\\ hemorrhage\ \(0\)\
\-\ \\Â\\»\\ abnormal\\ increased\\ attenuation\\ o\\.s\\.\ \(0\)\
\-\ \\Â\\»\\ fractures\\ left\\ orbit\\-\\ lateral\\,\\ posterior\\,\\ and\\ inferior\\ \\ walls\ \(0\)\
\-\ \\Â\\»\\ air\\ fluid\\ level\\ within\\ the\\ left\\ maxillary\\ sinus\ \(0\)\
\-\ rupture\\ of\\ the\\ left\\ globe\\ with\\ associated\\ orbital\\ wall\\ fractures\\.\ \(0\)\
\-\ blow\\-out\\ fracture\ \(2\)\
\-\ globe\\ rupture\ \(1\)\
\-\ globe\\ hemorrhage\ \(0\)\
\-\ ocular\\ tumor\ \(1\)\
\-\ presented\\ to\\ the\\ emergency\\ department\\ after\\ being\\ hit\\ in\\ the\\ face\\ by\\ a\\ softball\\.\ \(0\)\
\-\ with\\ rupture\\ of\\ the\\ globe\\,\\ this\\ patient\\ is\\ at\\ risk\\ for\\ sympathetic\\ ophthalmia\\.\\ \\ this\\ is\\ a\\ potentially\\ blinding\\ immune\\ mediated\\,\\ inflammatory\\ condition\\,\\ which\\ usually\\ follows\\ severe\\ trauma\\ to\\ one\\ eye\\.\\ the\\ mechanism\\ of\\ injury\\ must\\ be\\ a\\ traumatic\\ penetrating\\ or\\ rupturing\\ injury\\ to\\ the\\ eye\\ involving\\ the\\ region\\ of\\ the\\ ciliary\\ body\\.\\ \\ the\\ immune\\ system\\ becomes\\ exposed\\ to\\ antigens\\ in\\ the\\ eye\\ it\\ has\\ never\\ responded\\ to\\ before\\.\\ this\\ immune\\ system\\ reaction\\ can\\ then\\ result\\ in\\ complete\\ vision\\ loss\\ of\\ the\\ un\\-injured\\ eye\\.\ \(0\)\
\-\ treatment\\:\\ early\\ enucleation\\ within\\ two\\ weeks\\ of\\ injury\\ can\\ be\\ protective\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ globe\\:\\ 0\\.5175898681591928\ \(0\)\
\-\ the\\:\\ 0\\.24068709534346422\ \(0\)\
\-\ immune\\:\\ 0\\.2369546022154452\ \(0\)\
\-\ rupture\\:\\ 0\\.22945217450277108\ \(0\)\
\-\ eye\\:\\ 0\\.2270506730172763\ \(0\)\
\-\ enucleation\\:\\ 0\\.16966220037915503\ \(0\)\
\-\ left\\:\\ 0\\.1452254896918046\ \(0\)\
\-\ injury\\:\\ 0\\.13880997359263406\ \(0\)\
\-\ of\\:\\ 0\\.12496995809394572\ \(0\)\
\-\ ophthalmia\\:\\ 0\\.1134722587295712\ \(0\)\
\-\ blinding\\:\\ 0\\.1134722587295712\ \(0\)\
\-\ rupturing\\:\\ 0\\.10842880106145035\ \(0\)\
\-\ system\\:\\ 0\\.10826231536431219\ \(0\)\
\-\ fractures\\:\\ 0\\.10491406304600702\ \(0\)\
\-\ softball\\:\\ 0\\.09980695323034465\ \(0\)\
\-\ antigens\\:\\ 0\\.09980695323034465\ \(0\)\
\-\ enophthalmos\\:\\ 0\\.09622856306735982\ \(0\)\
\-\ ciliary\\:\\ 0\\.09622856306735982\ \(0\)\
\-\ protective\\:\\ 0\\.09622856306735982\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.09501211060060513\ \(0\)\
\-\ mediated\\:\\ 0\\.09476349556222377\ \(0\)\
\-\ exposed\\:\\ 0\\.09118510539923894\ \(0\)\
\-\ responded\\:\\ 0\\.08926767178368494\ \(0\)\
\-\ to\\:\\ 0\\.08869287082527295\ \(0\)\
\-\ sympathetic\\:\\ 0\\.0854691219421991\ \(0\)\
\-\ abnormal\\:\\ 0\\.08525745254668653\ \(0\)\
\-\ region\\:\\ 0\\.08488397339210071\ \(0\)\
\-\ periorbital\\:\\ 0\\.08256325756813324\ \(0\)\
\-\ depressed\\:\\ 0\\.07898486740514842\ \(0\)\
\-\ morphology\\:\\ 0\\.07560236628445838\ \(0\)\
\-\ hit\\:\\ 0\\.07530967755434333\ \(0\)\
\-\ associated\\:\\ 0\\.07479705805585897\ \(0\)\
\-\ penetrating\\:\\ 0\\.07474418485333577\ \(0\)\
\-\ never\\:\\ 0\\.07474418485333577\ \(0\)\
\-\ potentially\\:\\ 0\\.0744707958898688\ \(0\)\
\-\ can\\:\\ 0\\.07446971919866424\ \(0\)\
\-\ this\\:\\ 0\\.07314409705205206\ \(0\)\
\-\ ocular\\:\\ 0\\.0727088480127552\ \(0\)\
\-\ in\\:\\ 0\\.07060505975900817\ \(0\)\
\-\ maxillary\\:\\ 0\\.0703630195740427\ \(0\)\
\-\ follows\\:\\ 0\\.06942733822174793\ \(0\)\
\-\ damage\\:\\ 0\\.06907192269652694\ \(0\)\
\-\ becomes\\:\\ 0\\.06790232507235248\ \(0\)\
\-\ mechanism\\:\\ 0\\.06683331321922953\ \(0\)\
\-\ walls\\:\\ 0\\.06654402815505697\ \(0\)\
\-\ within\\:\\ 0\\.0653592356704418\ \(0\)\
\-\ face\\:\\ 0\\.06397020404550349\ \(0\)\
\-\ contour\\:\\ 0\\.0638544944007858\ \(0\)\
\-\ orbital\\:\\ 0\\.06223680293039792\ \(0\)\
\-\ vision\\:\\ 0\\.0614530037096223\ \(0\)\
\-\ must\\:\\ 0\\.060805490390642224\ \(0\)\
\-\ reaction\\:\\ 0\\.06036278540467828\ \(0\)\
\-\ department\\:\\ 0\\.060019627169677806\ \(0\)\
\-\ be\\:\\ 0\\.05756709542972276\ \(0\)\
\-\ before\\:\\ 0\\.05736304362569277\ \(0\)\
\-\ condition\\:\\ 0\\.056697714074816136\ \(0\)\
\-\ with\\:\\ 0\\.05557539005072362\ \(0\)\
\-\ attenuation\\:\\ 0\\.0542902903059779\ \(0\)\
\-\ traumatic\\:\\ 0\\.05376757906454408\ \(0\)\
\-\ result\\:\\ 0\\.053119323911831315\ \(0\)\
\-\ emergency\\:\\ 0\\.052642687165207126\ \(0\)\
\-\ sinus\\:\\ 0\\.051271497064990734\ \(0\)\
\-\ early\\:\\ 0\\.051146483981462945\ \(0\)\
\-\ risk\\:\\ 0\\.0506985610563429\ \(0\)\
\-\ then\\:\\ 0\\.05022763930963972\ \(0\)\
\-\ complete\\:\\ 0\\.04973682279114127\ \(0\)\
\-\ involving\\:\\ 0\\.04969985783939235\ \(0\)\
\-\ because\\:\\ 0\\.04958961755701813\ \(0\)\
\-\ being\\:\\ 0\\.04944413406102622\ \(0\)\
\-\ inferior\\:\\ 0\\.04827175528600524\ \(0\)\
\-\ inflammatory\\:\\ 0\\.04797906655589018\ \(0\)\
\-\ swelling\\:\\ 0\\.04775608778141599\ \(0\)\
\-\ body\\:\\ 0\\.046697479905451714\ \(0\)\
\-\ air\\:\\ 0\\.04641086130011393\ \(0\)\
\-\ patient\\:\\ 0\\.04615610409240903\ \(0\)\
\-\ severe\\:\\ 0\\.04491749185532931\ \(0\)\
\-\ usually\\:\\ 0\\.04466870962018228\ \(0\)\
\-\ and\\:\\ 0\\.043985855749474286\ \(0\)\
\-\ loss\\:\\ 0\\.04322829761788437\ \(0\)\
\-\ wall\\:\\ 0\\.04316265790297884\ \(0\)\
\-\ level\\:\\ 0\\.04286083761945533\ \(0\)\
\-\ weeks\\:\\ 0\\.042524636150357245\ \(0\)\
\-\ edema\\:\\ 0\\.042319033169959046\ \(0\)\
\-\ two\\:\\ 0\\.04213685208747381\ \(0\)\
\-\ presented\\:\\ 0\\.0413768519401642\ \(0\)\
\-\ trauma\\:\\ 0\\.041207870814581125\ \(0\)\
\-\ fluid\\:\\ 0\\.04096776972591243\ \(0\)\
\-\ one\\:\\ 0\\.040624984806751335\ \(0\)\
\-\ fracture\\:\\ 0\\.04032609007086505\ \(0\)\
\-\ is\\:\\ 0\\.038862937762762464\ \(0\)\
\-\ increased\\:\\ 0\\.038369011171998875\ \(0\)\
\-\ tumor\\:\\ 0\\.03711350549424202\ \(0\)\
\-\ posterior\\:\\ 0\\.03669136709519875\ \(0\)\
\-\ it\\:\\ 0\\.03632079812199553\ \(0\)\
\-\ had\\:\\ 0\\.03535231716264263\ \(0\)\
\-\ lateral\\:\\ 0\\.03521333586079211\ \(0\)\
\-\ after\\:\\ 0\\.03442136291373353\ \(0\)\
\-\ treatment\\:\\ 0\\.033799562024670285\ \(0\)\
\-\ has\\:\\ 0\\.03241010993239145\ \(0\)\
\-\ which\\:\\ 0\\.0322638781572884\ \(0\)\
\-\ by\\:\\ 0\\.030131546276020753\ \(0\)\
\-\ from\\:\\ 0\\.02818025990172961\ \(0\)\
\-\ an\\:\\ 0\\.027132898056938304\ \(0\)\
\-\ at\\:\\ 0\\.02680054668370296\ \(0\)\
\-\ or\\:\\ 0\\.024683930315492205\ \(0\)\
\-\ for\\:\\ 0\\.02150587174219014\ \(0\)\
